The new online portal offers a fully integrated shopping experience that aggregates, customizes, and streamlines the purchasing of reagents, including research, clinical, and single-cell multiomic products. Also, the portal provides integration with procurement buying systems, allowing purchasers to view institutional pricing and receive internal approvals before products are ordered.

Additionally, BD's new site offers updated search capabilities, more than 170 pages of new information, application data, and product selection tools. It also provides customized dashboards and 24-hour per day, seven-day per week order tracking and support tools.

The website launched in the U.S., Canada, Europe, Australia, and New Zealand, with other access coming to additional countries this summer.

The new BD Biosciences website offers a full array of BD research, clinical, and single-cell multiomic products. Image courtesy of BD.

BD posts healthy global, U.S. Q4 revenues
Becton Dickinson (BD) has reported worldwide fourth quarter revenues of $4.8 billion, up 4.4% compared to the same period in 2019. U.S. revenues...

BD names new executive vice presidents
Becton Dickinson (BD) has appointed Patrick Kaltenbach as executive vice president and chief technology officer. The firm also promoted Dave Hickey to...

BD granted FDA clearance for sample preparation system
Becton Dickinson (BD) announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an integrated sample preparation...

BD to provide injection devices for mass doses of COVID-19 vaccines
Becton Dickinson (BD) formed a strategic partnership with the Biomedical Advanced Research and Development Authority to develop new manufacturing lines...

BD revenues edge up for 2nd quarter
Becton Dickinson (BD) saw its revenues grow slightly for the second quarter, but the company withdrew its previously issued guidance due to fallout from...